Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PDGFRB C843G
i
Other names:
PDGFRB, Platelet Derived Growth Factor Receptor Beta, Platelet-Derived Growth Factor Receptor, Beta Polypeptide, Beta-Type Platelet-Derived Growth Factor Receptor, Platelet-Derived Growth Factor Receptor Beta, Platelet-Derived Growth Factor Receptor 1, CD140 Antigen-Like Family Member B, PDGF-R-Beta, PDGFR-Beta, PDGFR-1, PDGFR1,Beta Platelet-Derived Growth Factor Receptor, Activated Tyrosine Kinase PDGFRB, CD140b Antigen, NDEL1-PDGFRB , CD140B, IBGC4, JTK12, PENTT, IMF1 , KOGS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5159
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
PDGFRB overexpression (6)
ALK expression + PDGFRB expression (1)
KDR overexpression + PDGFRB overexpression (1)
PDGFRB underexpression (1)
PDGFRB overexpression (6)
ALK expression + PDGFRB expression (1)
KDR overexpression + PDGFRB overexpression (1)
PDGFRB underexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PDGFRB C843G
Acute Lymphocytic Leukemia
PDGFRB C843G
Acute Lymphocytic Leukemia
imatinib
Resistant: D – Preclinical
imatinib
Resistant
:
D
imatinib
Resistant: D – Preclinical
imatinib
Resistant
:
D
PDGFRB C843G
Acute Lymphocytic Leukemia
PDGFRB C843G
Acute Lymphocytic Leukemia
dasatinib
Resistant: D – Preclinical
dasatinib
Resistant
:
D
dasatinib
Resistant: D – Preclinical
dasatinib
Resistant
:
D
PDGFRB C843G
Acute Lymphocytic Leukemia
PDGFRB C843G
Acute Lymphocytic Leukemia
ponatinib
Resistant: D – Preclinical
ponatinib
Resistant
:
D
ponatinib
Resistant: D – Preclinical
ponatinib
Resistant
:
D
PDGFRB C843G
Acute Lymphocytic Leukemia
PDGFRB C843G
Acute Lymphocytic Leukemia
nilotinib
Resistant: D – Preclinical
nilotinib
Resistant
:
D
nilotinib
Resistant: D – Preclinical
nilotinib
Resistant
:
D
PDGFRB C843G
Acute Lymphocytic Leukemia
PDGFRB C843G
Acute Lymphocytic Leukemia
CHZ868
Sensitive: D – Preclinical
CHZ868
Sensitive
:
D
CHZ868
Sensitive: D – Preclinical
CHZ868
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.